Literature DB >> 2998399

Free radical damage to deoxyribose by anthracycline, aureolic acid and aminoquinone antitumour antibiotics. An essential requirement for iron, semiquinones and hydrogen peroxide.

J M Gutteridge, G J Quinlan.   

Abstract

Anthracycline, aureolic acid and aminoquinone antitumour antibiotics damage deoxyribose in cell-free systems when reduced in air by the enzyme ferredoxin reductase. Damage to deoxyribose is inhibited by the iron chelator desferrioxamine, the copper-containing protein caeruloplasmin and catalase but not by superoxide dismutase. Scavengers of the hydroxyl radical such as formate, butan-1-ol, ethanol and benzoate do not offer much protection, whereas mannitol and thiourea do. These findings point to a site-specific Fenton reaction in which the drug semiquinones reduce complexed iron and dioxygen leading to the formation of hydrogen peroxide and a ferrous complex.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2998399     DOI: 10.1016/0006-2952(85)90200-x

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  6 in total

Review 1.  Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.

Authors:  J Bouma; J H Beijnen; A Bult; W J Underberg
Journal:  Pharm Weekbl Sci       Date:  1986-04-25

2.  Hydroxyl-radical-induced iron-catalysed degradation of 2-deoxyribose. Quantitative determination of malondialdehyde.

Authors:  K H Cheeseman; A Beavis; H Esterbauer
Journal:  Biochem J       Date:  1988-06-15       Impact factor: 3.857

3.  Decreased resistance to N,N-dimethylated anthracyclines in multidrug-resistant Friend erythroleukemia cells.

Authors:  A Schaefer; J Westendorf; K Lingelbach; C A Schmidt; D L Mihalache; A Reymann; H Marquardt
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

Review 4.  Chemophototherapy: An Emerging Treatment Option for Solid Tumors.

Authors:  Dandan Luo; Kevin A Carter; Dyego Miranda; Jonathan F Lovell
Journal:  Adv Sci (Weinh)       Date:  2016-05-24       Impact factor: 16.806

5.  Triggering autophagic cell death with a di-manganese(II) developmental therapeutic.

Authors:  Creina Slator; Zara Molphy; Vickie McKee; Andrew Kellett
Journal:  Redox Biol       Date:  2017-02-04       Impact factor: 11.799

6.  Reversal of Doxorubicin-Induced Bone Loss and Mineralization by Supplementation of Resveratrol and MitoTEMPO in the Early Development of Sparus aurata.

Authors:  Sunil Poudel; Marisol Izquierdo; Maria Leonor Cancela; Paulo J Gavaia
Journal:  Nutrients       Date:  2022-03-09       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.